VIM and cancer: The upregulation of gene products associated with migration and invasion (osteopontin, MMP1, vimentin, filamin-A, and β-actin) and gene products for extracellular matrix molecules and their modulators (fibronectin, collagen, ITGBL1, and MXRA5) reflects the invasive nature of this cancer.